Literature DB >> 24465028

Revival of 5-HT3 antagonism as treatment of IBS-D?

Giovanni Barbara.   

Abstract

Keywords:  CLINICAL TRIALS; DIARRHOEA; IRRITABLE BOWEL SYNDROME; PHARMACOTHERAPY; SEROTONIN

Mesh：

Substances：

Year:  2014        PMID： 24465028     DOI： 10.1136/gutjnl-2013-306457

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  3 in total

1.  Association of genetic polymorphisms in HTR3A and HTR3E with diarrhea predominant irritable bowel syndrome.

Authors:  Qiao-Yan Gu; Jun Zhang; Yi-Chao Feng; Guang-Rong Dai; Wei-Ping Du
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.

Authors:  Feng-Yan Yu; Shao-Gang Huang; Hai-Yan Zhang; Hua Ye; Hong-Gang Chi; Ying Zou; Ru-Xi Lv; Xue-Bao Zheng
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

Review 3.  Spotlight on eluxadoline for the treatment of patients with irritable bowel syndrome with diarrhea.

Authors:  Konstantinos C Fragkos
Journal:  Clin Exp Gastroenterol       Date:  2017-09-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.